1. Home
  2. LSTA vs NTIP Comparison

LSTA vs NTIP Comparison

Compare LSTA & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • NTIP
  • Stock Information
  • Founded
  • LSTA 1980
  • NTIP 1990
  • Country
  • LSTA United States
  • NTIP United States
  • Employees
  • LSTA N/A
  • NTIP N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • NTIP Multi-Sector Companies
  • Sector
  • LSTA Health Care
  • NTIP Miscellaneous
  • Exchange
  • LSTA Nasdaq
  • NTIP Nasdaq
  • Market Cap
  • LSTA 22.5M
  • NTIP 28.6M
  • IPO Year
  • LSTA N/A
  • NTIP 1998
  • Fundamental
  • Price
  • LSTA $2.61
  • NTIP $1.37
  • Analyst Decision
  • LSTA Strong Buy
  • NTIP
  • Analyst Count
  • LSTA 1
  • NTIP 0
  • Target Price
  • LSTA $15.00
  • NTIP N/A
  • AVG Volume (30 Days)
  • LSTA 23.5K
  • NTIP 25.7K
  • Earning Date
  • LSTA 08-11-2025
  • NTIP 08-11-2025
  • Dividend Yield
  • LSTA N/A
  • NTIP 7.52%
  • EPS Growth
  • LSTA N/A
  • NTIP N/A
  • EPS
  • LSTA N/A
  • NTIP N/A
  • Revenue
  • LSTA $1,000,000.00
  • NTIP $250,000.00
  • Revenue This Year
  • LSTA N/A
  • NTIP N/A
  • Revenue Next Year
  • LSTA N/A
  • NTIP N/A
  • P/E Ratio
  • LSTA N/A
  • NTIP N/A
  • Revenue Growth
  • LSTA N/A
  • NTIP N/A
  • 52 Week Low
  • LSTA $1.87
  • NTIP $1.16
  • 52 Week High
  • LSTA $4.20
  • NTIP $1.78
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 52.43
  • NTIP 62.14
  • Support Level
  • LSTA $2.34
  • NTIP $1.20
  • Resistance Level
  • LSTA $3.09
  • NTIP $1.30
  • Average True Range (ATR)
  • LSTA 0.25
  • NTIP 0.06
  • MACD
  • LSTA 0.01
  • NTIP 0.01
  • Stochastic Oscillator
  • LSTA 50.67
  • NTIP 69.23

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: